Dr. Gustavo Velásquez featured in "The Dose" podcast

In honor of World TB Day, the Working Group on New TB Drugs (WGND) has released the next episode of their podcast, The Dose.  The episode, "Highly Drug-Resistant TB & ZeNix Trial Results" features Dr. Francesca Conradie, and Center for TB faculty member, Dr. Gustavo Velásquez, discussing the most highly drug-resistant forms of TB, The fifth episode will also focus on the results from ZeNix, a Phase 3 clinical trial, that explored potential optimization of a regimen for treating patients with highly drug-resistant TB. Link to podcast episode